Occlutech International AB
Landskronavägen 2
Sweden
Phone:
+46 (42) 33 65 21
Product Categories:
Related Content
News | Heart Failure | February 24, 2021
February 24, 2021 — Occlutech announced the completion of patient enrollment in the PRELIEVE trial, pilot study to as
The Occlutech implantable Atrial Flow Regulator (AFR) maintains an interatrial shunt with a predetermined diameter allowing for controlled blood flow from the left to the right atrium enabling the left atrium to decompress and lower left atrial pressure. This reduced left atrial pressure reduces heart failure symptoms and improves exercise tolerance.
News | Heart Failure | January 27, 2021
January, 27, 2021 — The U.S.
Transcatheter repair of a surgical mitral replacement paravalvular leak with an Amplatzer Vascular Plug II.
Feature | Heart Valve Technology | February 08, 2016 | Dave Fornell
Off-label use of the St.
News | October 07, 2014
Occlutech announced that it has obtained a European CE mark approval for its dedicated Paravalvular Leak Closure...
News | August 01, 2014
Occlutech announced that it has successfully obtained a ruling by the U.K. Patents Court in the High Court of Justice...
News | May 31, 2012
May 31, 2012 —Occlutech GmbH, the leading European developer of minimally invasive implants for the treatment of...
News | September 27, 2011
September 27, 2011 — Occlutech announced its CEO, Tor Peters, has obtained a favorable ruling from the district court...
Feature | August 25, 2011
August 25, 2011 – Transcatheter structural heart occluder maker Occlutech said this week it closed a 15 million Euro...
News | May 16, 2011
May 16, 2011 - The German Supreme Court (BGH) declared a structural heart occluder patent case to be invalid. In the...
News | June 27, 2010
June 28, 2010 – AGA Medical has been denied the right to appeal a decision in a United Kingdom patent case concerning...
